Clinical outcomes of patients with coronary microvascular dysfunction in absence of obstructive coronary

Antonio De Vita1, Carmine Pizzi2, Isabella Tritto3

  • 1Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Dipartimento di Medicina Cardiovascolare, Rome.

Insights

Coronary microvascular dysfunction (CMD) causes chest pain in patients with normal arteries. Prognosis varies: excellent for microvascular angina, but needs more study in acute coronary syndromes.

Area of Science:

  • Cardiology
  • Vascular Medicine

Background:

  • Many patients with chest pain have normal coronary arteries on angiography.
  • Coronary microvascular dysfunction (CMD) is increasingly recognized as a cause of angina in these individuals.
  • Prognosis for patients with non-obstructive coronary artery disease and angina is debated.

Purpose of the Study:

  • To critically review studies on the clinical outcomes of patients with angina and non-obstructive coronary artery disease.
  • To assess the prognostic impact of coronary microvascular dysfunction (CMD) in different clinical presentations.

Main Methods:

  • Review of published literature on clinical outcomes.
  • Analysis of studies involving patients with stable angina or acute coronary syndrome and normal/near-normal coronary arteries.
  • Focus on studies assessing the role of coronary microvascular dysfunction (CMD).

Main Results:

  • Patient populations in studies are heterogeneous.
  • Presence of non-obstructive atherosclerotic coronary artery disease significantly impacts clinical outcome.
  • Long-term prognosis appears excellent for patients with totally normal coronary arteries and CMD-related stable angina (microvascular angina).

Conclusions:

  • The prognosis for patients with angina and non-obstructive coronary artery disease depends heavily on the underlying coronary pathology.
  • Microvascular angina in patients with completely normal coronary arteries has an excellent long-term prognosis.
  • Further research is needed to clarify the prognostic impact of CMD in patients presenting with acute coronary syndromes.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
30
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
29
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
32
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
43